Charles Schwab Investment Management Inc. Acquires 38,810 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

Charles Schwab Investment Management Inc. raised its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 5.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 772,746 shares of the company's stock after buying an additional 38,810 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.61% of Surgery Partners worth $24,913,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in SGRY. Royce & Associates LP boosted its holdings in shares of Surgery Partners by 12.2% in the third quarter. Royce & Associates LP now owns 510,261 shares of the company's stock valued at $16,451,000 after acquiring an additional 55,545 shares in the last quarter. Lombard Odier Asset Management Europe Ltd acquired a new position in Surgery Partners in the second quarter worth approximately $4,163,000. Principal Financial Group Inc. acquired a new stake in shares of Surgery Partners during the third quarter worth $1,469,000. Rhumbline Advisers grew its position in Surgery Partners by 19.6% during the 2nd quarter. Rhumbline Advisers now owns 127,952 shares of the company's stock worth $3,044,000 after purchasing an additional 20,963 shares in the last quarter. Finally, Point72 Asset Management L.P. acquired a new stake in Surgery Partners during the 2nd quarter valued at $29,288,000.

Analysts Set New Price Targets

Several research firms recently weighed in on SGRY. UBS Group assumed coverage on Surgery Partners in a research report on Monday, October 14th. They set a "buy" rating and a $38.00 price target on the stock. KeyCorp started coverage on shares of Surgery Partners in a research report on Friday, October 11th. They set a "sector weight" rating on the stock. JPMorgan Chase & Co. cut their target price on shares of Surgery Partners from $38.00 to $28.00 and set a "neutral" rating for the company in a research report on Tuesday. Benchmark restated a "buy" rating and set a $50.00 price target on shares of Surgery Partners in a report on Monday, August 26th. Finally, Macquarie reiterated an "outperform" rating and set a $34.00 price objective on shares of Surgery Partners in a report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $37.38.

Surgery Partners Stock Up 2.0 %

Shares of SGRY traded up $0.43 during trading hours on Friday, hitting $21.89. 1,372,634 shares of the company were exchanged, compared to its average volume of 979,569. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The company has a market cap of $2.78 billion, a PE ratio of -44.71, a PEG ratio of 19.15 and a beta of 2.58. The firm's 50 day moving average is $28.20 and its 200-day moving average is $28.12. Surgery Partners, Inc. has a 52 week low of $21.10 and a 52 week high of $36.92.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company had revenue of $770.40 million for the quarter, compared to analyst estimates of $768.99 million. During the same quarter last year, the business earned $0.15 EPS. The company's revenue for the quarter was up 14.3% on a year-over-year basis. On average, equities research analysts forecast that Surgery Partners, Inc. will post 0.73 EPS for the current fiscal year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.